Cargando…
Beta Cell Dysfunction and Insulin Resistance
Beta cell dysfunction and insulin resistance are inherently complex with their interrelation for triggering the pathogenesis of diabetes also somewhat undefined. Both pathogenic states induce hyperglycemia and therefore increase insulin demand. Beta cell dysfunction results from inadequate glucose s...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608918/ https://www.ncbi.nlm.nih.gov/pubmed/23542897 http://dx.doi.org/10.3389/fendo.2013.00037 |
_version_ | 1782264287746588672 |
---|---|
author | Cerf, Marlon E. |
author_facet | Cerf, Marlon E. |
author_sort | Cerf, Marlon E. |
collection | PubMed |
description | Beta cell dysfunction and insulin resistance are inherently complex with their interrelation for triggering the pathogenesis of diabetes also somewhat undefined. Both pathogenic states induce hyperglycemia and therefore increase insulin demand. Beta cell dysfunction results from inadequate glucose sensing to stimulate insulin secretion therefore elevated glucose concentrations prevail. Persistently elevated glucose concentrations above the physiological range result in the manifestation of hyperglycemia. With systemic insulin resistance, insulin signaling within glucose recipient tissues is defective therefore hyperglycemia perseveres. Beta cell dysfunction supersedes insulin resistance in inducing diabetes. Both pathological states influence each other and presumably synergistically exacerbate diabetes. Preserving beta cell function and insulin signaling in beta cells and insulin signaling in the glucose recipient tissues will maintain glucose homeostasis. |
format | Online Article Text |
id | pubmed-3608918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-36089182013-03-29 Beta Cell Dysfunction and Insulin Resistance Cerf, Marlon E. Front Endocrinol (Lausanne) Endocrinology Beta cell dysfunction and insulin resistance are inherently complex with their interrelation for triggering the pathogenesis of diabetes also somewhat undefined. Both pathogenic states induce hyperglycemia and therefore increase insulin demand. Beta cell dysfunction results from inadequate glucose sensing to stimulate insulin secretion therefore elevated glucose concentrations prevail. Persistently elevated glucose concentrations above the physiological range result in the manifestation of hyperglycemia. With systemic insulin resistance, insulin signaling within glucose recipient tissues is defective therefore hyperglycemia perseveres. Beta cell dysfunction supersedes insulin resistance in inducing diabetes. Both pathological states influence each other and presumably synergistically exacerbate diabetes. Preserving beta cell function and insulin signaling in beta cells and insulin signaling in the glucose recipient tissues will maintain glucose homeostasis. Frontiers Media S.A. 2013-03-27 /pmc/articles/PMC3608918/ /pubmed/23542897 http://dx.doi.org/10.3389/fendo.2013.00037 Text en Copyright © 2013 Cerf. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc. |
spellingShingle | Endocrinology Cerf, Marlon E. Beta Cell Dysfunction and Insulin Resistance |
title | Beta Cell Dysfunction and Insulin Resistance |
title_full | Beta Cell Dysfunction and Insulin Resistance |
title_fullStr | Beta Cell Dysfunction and Insulin Resistance |
title_full_unstemmed | Beta Cell Dysfunction and Insulin Resistance |
title_short | Beta Cell Dysfunction and Insulin Resistance |
title_sort | beta cell dysfunction and insulin resistance |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608918/ https://www.ncbi.nlm.nih.gov/pubmed/23542897 http://dx.doi.org/10.3389/fendo.2013.00037 |
work_keys_str_mv | AT cerfmarlone betacelldysfunctionandinsulinresistance |